Eliminating Viral Hepatitis in Turkey: Achievements and Challenges

Basit Öğe Kaydı
dc.authoridGUNER, RAHMET/0000-0002-1029-1185
dc.authoridAkarca, Ulus Salih/0000-0002-7020-5816
dc.authoridBaykam, Nurcan/0000-0002-2398-8686
dc.authorwosidBaykam, Nurcan/A-6882-2018
dc.contributor.authorAkarca, Ulus Salih
dc.contributor.authorBaykam, Nurcan
dc.contributor.authorGuner, Rahmet
dc.contributor.authorGunsar, Fulya
dc.contributor.authorIdilman, Ramazan
dc.contributor.authorKaymakoglu, Sabahattin
dc.contributor.authorKoksal, Iftihar
dc.date.accessioned2023-01-12T20:17:03Z
dc.date.available2023-01-12T20:17:03Z
dc.date.issued2022
dc.departmentN/A/Departmenten_US
dc.description.abstractAfter the declaration Global Health Sector Strategy on Viral Hepatitis by the World Health Organization in 2016, the Turkish Government defined a national strategy covering 2018-2023 to reach goals by 2030. Following a participatory decision process and a series of workshops, the strategy was built on eight separate subheadings. Apart from the official Prevention and Control Program, two separate road maps for hepatitis B and C were developed to obtain targets accessible with the cooperation of the Viral Hepatitis Society and the Turkish Association for the Study of the Liver in 2018 and 2020, respectively. Up to 2023, achievements and the current situation of the National Viral Hepatitis Prevention and Control Program and the hepatitis B virus and hepatitis C virus road maps were assessed in detail on June 28th, 2022, by the subject matter experts in Turkey. Besides the officially reported achievement rate (42%) of the Program in 2021, participants mentioned undesirable effects of the coronavirus disease-2019 pandemic, unregulated migration, low levels of professional and public awareness, and barriers to access to anti-viral treatment. Recommendations focused on increasing the efficiency of screening and surveillance by integrating the viral carrier identity of individuals into the national health information system, simplifying the drug supplement and treatment initiation process and insisting on education to raise awareness.en_US
dc.identifier.doi10.4274/vhd.galenos.2022.2022-9-1
dc.identifier.endpage54en_US
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issn1307-9441en_US
dc.identifier.issn2147-2939en_US
dc.identifier.issue2en_US
dc.identifier.startpage47en_US
dc.identifier.urihttps://doi.org/10.4274/vhd.galenos.2022.2022-9-1
dc.identifier.urihttps://hdl.handle.net/11454/78815
dc.identifier.volume28en_US
dc.identifier.wosWOS:000870481200002en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journalen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectHBVen_US
dc.subjectHCVen_US
dc.subjectB-Virus Infectionen_US
dc.subjectC Virusen_US
dc.titleEliminating Viral Hepatitis in Turkey: Achievements and Challengesen_US
dc.typeReviewen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu